April 17, 2014
/PRNewswire/ -- Teva Pharmaceuticals, makers of AZILECT® (rasagiline tablets) a once-daily treatment for Parkinson's disease (PD), and the Parkinson's Unity Walk (PUW) announces the launch of a public awareness campaign, "CommUNITY: Carrying the PD Torch," to support Parkinson's disease (PD) patients during Parkinson's Disease Awareness Month in April. The campaign aims to empower patients to set their goals and work to achieve them by uniting the community and encouraging patients in their PD journey.
To view the multimedia content associated with this release, please click:
The "CommUNITY: Carrying the PD Torch," campaign kicked off on
12 PM EST
at the Rocky monument, which was blanketed in tulips, the worldwide symbol of PD. A Parkinson's disease patient,
, was onsite to share her experience with Parkinson's disease and
Daniel Kremens M.D
., Jefferson University Hospital Physician and Co-Director, Movement Disorders Program, spoke on recent developments in PD.
The campaign will culminate at the 20th Annual Parkinson's Unity Walk in Central Park on
, where a torch of tulips will be brought from the Rocky monument to the Teva booth at the Walk. The Parkinson's Unity Walk is the largest grassroots fundraiser for Parkinson's research in the country and 100 percent of donations support research funded by seven major Parkinson's organizations. Attendees at the Parkinson's Unity Walk are encouraged to visit Teva's booth for information on Parkinson's disease and to participate in a goal-reaching activity.
"We're extremely pleased to partner with Teva during PD Awareness Month," said
, CEO of The Parkinson Alliance, the umbrella organization for the Parkinson's Unity Walk. "It's important to bring together patients and educate the community about PD."
"Having a strong community support system – my family, friends and a dedicated health care team is what has allowed me to live my life to the fullest, despite my diagnosis," said
. "It is important to raise awareness for PD so the community has a better understanding of the disease and the patient journey."
To learn more about Parkinson's disease, please visit ParkinsonsHealth.com.